Biointron is a high-throughput recombinant antibody and protein expression and discovery service provider. Founded in 2012 and certified to ISO 9001:2015, Biointron offers antibody discovery (VHH, single B cell screening and fully human), antibody optimization, antibody production, recombinant protein expression, stable cell line development and developability assessment. The company has delivered tens of thousands of recombinant antibodies for 3,000+ biotech and pharmaceutical companies worldwide, with US offices in Cambridge, MA and Piscataway, NJ.

Website: https://www.biointron.com